QUIDELORTHO CORP Goodwill, Foreign Currency Translation Gain (Loss)
QUIDELORTHO CORP (QDEL) reported Goodwill, Foreign Currency Translation Gain (Loss) of $51.20 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-19.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-02-19
- QUIDELORTHO CORP goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-28 was $0.00.
- QUIDELORTHO CORP goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-28 was -$10.40M, a 127.30% decline year-over-year.
- QUIDELORTHO CORP goodwill, foreign currency translation gain (loss) for the quarter ending 2025-06-29 was $40.20M.
- QUIDELORTHO CORP goodwill, foreign currency translation gain (loss) for the quarter ending 2025-03-30 was $21.40M.
- QUIDELORTHO CORP goodwill, foreign currency translation gain (loss) for fiscal 2025 was $51.20M.
- QUIDELORTHO CORP goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$19.90M, a 156.70% decline from fiscal 2023.
- QUIDELORTHO CORP goodwill, foreign currency translation gain (loss) for fiscal 2023 was $35.10M.
- QUIDELORTHO CORP goodwill, foreign currency translation gain (loss) for fiscal 2023 was -$38.60M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$10.40M derived: sum of 2 quarters · filed 2026-02-19 | $29.80M derived: sum of 3 quarters · filed 2026-02-19 | $51.20M 10-K · filed 2026-02-19 |
| 2025-09-28 | -$10.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $29.80M derived: sum of 2 quarters · filed 2025-11-06 | $51.20M 10-Q · filed 2025-11-06 | $8.80M derived: sum of 4 quarters · filed 2026-02-19 |
| 2025-06-29 | $40.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $61.60M 10-Q · filed 2025-08-06 | $19.20M derived: sum of 3 quarters · filed 2026-02-19 | $57.30M derived: sum of 4 quarters · filed 2026-02-19 |
| 2025-03-30 | $21.40M 10-Q · filed 2025-05-08 | -$21.00M derived: sum of 2 quarters · filed 2026-02-19 | $17.10M derived: sum of 3 quarters · filed 2026-02-19 | $14.80M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-12-29 | -$42.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$4.30M derived: sum of 2 quarters · filed 2026-02-19 | -$6.60M derived: sum of 3 quarters · filed 2026-02-19 | -$19.90M 10-K · filed 2026-02-19 |
| 2024-09-29 | $38.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $35.80M derived: sum of 2 quarters · filed 2024-11-08 | $22.50M 10-Q · filed 2024-11-08 | $67.60M derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-06-30 | -$2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$15.60M 10-Q · filed 2024-08-01 | $29.50M derived: sum of 3 quarters · filed 2025-02-27 | $1.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | -$13.30M 10-Q · filed 2024-05-09 | $31.80M derived: sum of 2 quarters · filed 2025-02-27 | $3.80M derived: sum of 3 quarters · filed 2025-02-27 | $4.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | $45.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $17.10M derived: sum of 2 quarters · filed 2025-02-27 | $17.80M derived: sum of 3 quarters · filed 2025-02-27 | $35.10M 10-K · filed 2025-02-27 |
| 2023-10-01 | -$28.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$27.30M derived: sum of 2 quarters · filed 2023-11-02 | -$10.00M 10-Q · filed 2023-11-02 | |
| 2023-07-02 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $18.00M 10-Q · filed 2023-08-09 | ||
| 2023-04-02 | $17.30M 10-Q · filed 2023-05-04 | |||
| 2023-01-01 | -$38.60M 10-K/A · filed 2024-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |